Literature DB >> 23706888

Anhedonia: a concept analysis.

Nancy Ho1, Marilyn Sommers.   

Abstract

Anhedonia presents itself in a myriad of disease processes. To further develop our understanding of anhedonia and effective ways to manage it, the concept requires clear boundaries. This paper critically examined the current scientific literature and conducted a concept analysis of anhedonia to provide a more accurate and lucid understanding of the concept. As part of the concept analysis, this paper also provides model, borderline, related, and contrary examples of anhedonia.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23706888      PMCID: PMC3664836          DOI: 10.1016/j.apnu.2013.02.001

Source DB:  PubMed          Journal:  Arch Psychiatr Nurs        ISSN: 0883-9417            Impact factor:   2.218


  108 in total

Review 1.  A new perspective on anhedonia in schizophrenia.

Authors:  Gregory P Strauss; James M Gold
Journal:  Am J Psychiatry       Date:  2012-04       Impact factor: 18.112

Review 2.  Avolition and expressive deficits capture negative symptom phenomenology: implications for DSM-5 and schizophrenia research.

Authors:  Julie W Messinger; Fabien Trémeau; Daniel Antonius; Erika Mendelsohn; Vasthie Prudent; Arielle D Stanford; Dolores Malaspina
Journal:  Clin Psychol Rev       Date:  2010-09-18

3.  Suboptimal glycemic control in type 2 diabetes: a key role for anhedonia?

Authors:  G Nefs; F Pouwer; J Denollet; H Kramer; C J M Wijnands-van Gent; V J M Pop
Journal:  J Psychiatr Res       Date:  2012-01-28       Impact factor: 4.791

4.  Posttraumatic stress and related symptoms among neglected and physically and sexually maltreated adolescents.

Authors:  Adrianna Wechsler-Zimring; Christopher A Kearney
Journal:  J Trauma Stress       Date:  2011-09-01

5.  Theory of Mind and psychometric schizotypy.

Authors:  Diane Carol Gooding; Madeline Johnson Pflum
Journal:  Psychiatry Res       Date:  2011-05-19       Impact factor: 3.222

6.  Ventral striatum response during reward and punishment reversal learning in unmedicated major depressive disorder.

Authors:  Oliver J Robinson; Roshan Cools; Christina O Carlisi; Barbara J Sahakian; Wayne C Drevets
Journal:  Am J Psychiatry       Date:  2012-02       Impact factor: 18.112

7.  Anhedonia is an important factor of health-related quality-of-life deficit in schizophrenia and schizoaffective disorder.

Authors:  Michael S Ritsner; Marina Arbitman; Alexander Lisker
Journal:  J Nerv Ment Dis       Date:  2011-11       Impact factor: 2.254

8.  Patterns of emotional experience in schizophrenia: differences in emotional response to visual stimuli are associated with clinical presentation and functional outcome.

Authors:  Gregory P Strauss; Ellen S Herbener
Journal:  Schizophr Res       Date:  2011-02-18       Impact factor: 4.939

Review 9.  Negative symptoms in schizophrenia: avolition and Occam's razor.

Authors:  George Foussias; Gary Remington
Journal:  Schizophr Bull       Date:  2008-07-21       Impact factor: 9.306

10.  Mood induction in depressive patients: a comparative multidimensional approach.

Authors:  Irina Falkenberg; Nils Kohn; Regina Schoepker; Ute Habel
Journal:  PLoS One       Date:  2012-01-09       Impact factor: 3.240

View more
  16 in total

1.  Assessment of Snaith-Hamilton Pleasure Scale (SHAPS): the dimension of anhedonia in Italian healthy sample.

Authors:  Iolanda Martino; Gabriella Santangelo; Daniela Moschella; Luana Marino; Rocco Servidio; Antonio Augimeri; Angela Costabile; Giovanni Capoderose; Antonio Cerasa
Journal:  Neurol Sci       Date:  2018-01-30       Impact factor: 3.307

2.  Psychosocial factors and multiple health risk behaviors among early adolescents: a latent profile analysis.

Authors:  Christopher M Warren; Afton Kechter; Georgia Christodoulou; Christopher Cappelli; Mary Ann Pentz
Journal:  J Behav Med       Date:  2020-04-22

3.  Possible New Symptoms of Tobacco Withdrawal II: Anhedonia-A Systematic Review.

Authors:  John R Hughes; Elias M Klemperer; Catherine Peasley-Miklus
Journal:  Nicotine Tob Res       Date:  2020-01-27       Impact factor: 4.244

4.  The Transdiagnostic Nature of Social Anhedonia: Historical and Current Perspectives.

Authors:  Diane Carol Gooding; Madeline Pflum
Journal:  Curr Top Behav Neurosci       Date:  2022

Review 5.  Possible New Symptoms of Tobacco Withdrawal III: Reduced Positive Affect-A Review and Meta-analysis.

Authors:  Elias M Klemperer; John R Hughes; Catherine E Peasley-Miklus; Peter W Callas; Jessica W Cook; Joanna M Streck; Nicolas E Morley
Journal:  Nicotine Tob Res       Date:  2021-01-22       Impact factor: 4.244

6.  Anhedonia as a key clinical feature in the maintenance and treatment of opioid use disorder.

Authors:  Brian D Kiluk; Sarah W Yip; Elise E DeVito; Kathleen M Carroll; Mehmet Sofuoglu
Journal:  Clin Psychol Sci       Date:  2019-09-23

7.  Development of a Self-Report Measure of Reward Sensitivity:A Test in Current and Former Smokers.

Authors:  John R Hughes; Peter W Callas; Jeff S Priest; Jean-Francois Etter; Alan J Budney; Stacey C Sigmon
Journal:  Nicotine Tob Res       Date:  2017-06-01       Impact factor: 4.244

8.  Serotonin transporter clustering in blood lymphocytes predicts the outcome on anhedonia scores in naïve depressive patients treated with antidepressant medication.

Authors:  Jose Manuel Olivares; Hector J Caruncho; Tania Rivera-Baltanas; Roberto Carlos Agis-Balboa; Raquel Romay-Tallon; Lisa E Kalynchuk
Journal:  Ann Gen Psychiatry       Date:  2015-12-21       Impact factor: 3.455

9.  Anhedonia in tobacco withdrawal among African-American smokers.

Authors:  Madalyn M Liautaud; Afton Kechter; Mariel S Bello; Casey R Guillot; Jason A Oliver; Devin E Banks; Lina M D'Orazio; Adam M Leventhal
Journal:  Exp Clin Psychopharmacol       Date:  2021-06-10       Impact factor: 3.492

10.  Social defeat-induced anhedonia: effects on operant sucrose-seeking behavior.

Authors:  Danai Riga; J Trisna Theijs; Taco J De Vries; August B Smit; Sabine Spijker
Journal:  Front Behav Neurosci       Date:  2015-08-07       Impact factor: 3.558

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.